Skip to main content
. 2020 Dec 16;10:22023. doi: 10.1038/s41598-020-79146-9

Figure 5.

Figure 5

Changes in physiologic parameters and urine-protein by administration of deferasirox. Body weight (a), Systolic blood pressure (b), Urine volume for 24 h (c), and Urine-protein for 24 h (d) in the control (n = 6), the HS (n = 6) and the HSDFX (n = 4) groups. Statistical analysis for each time-point was performed using one-way analysis of variance followed by Tukey–Kramer test in (a), (b), (c), and (d) by JMP Pro Version 14.2.0 software (SAS Institute Inc.). *p < 0.05 vs. the control group.